Industry professionals met in Bologna, Italy last week for a conference held at SANA, the international natural products trade fair, to discuss the future of their sector. From April 2011, all member states will have to comply with a European Union directive which specifies that all herbs produced, manufactured and sold in the EU must be classified as either foods or medicines.
petition wrote:[...] as strict censorship also means we can no longer speak or teach each other about the merits and health enhancing benefits of natural foods, [...]
Meanwhile, UK Regulators [...] are currently criminalizing' legitimate manufacturers & practitioners with heavy fines imprisonment, [...] These Regulators have been given more powers than the police [...]
petition wrote:The inspiration behind the petition is founder - Dounne Alexander (61) MBE, FRSA whose business (GRAMMA'S) and extraordinary herbal products have been effected by these draconian legislations.
The bottom line is that the Big Pharma companies want to be in control of herbal medicine. And they've got a lot of clout.
Dendrias wrote:Whether or not I like homeopathic medicine seems at least irrelevant in this thread. But perhaps this seemingly aggressive argumentum ad personam against me is meant to vilify my pov, and perhaps will serve for that..
It is so difficult to find a balanced view, and the "this site" mentioned by Dendrias is equally unbalanced, but in the opposite way. He definitely doesn't ike homoeopathy, does he!
Why is vitamin B17 banned in the UK? You won't find it in Any preparation, in any supplement, in any health shop... Because it can prevent and help cure Cancer - by softening the sticky coating on the cancer, so that your body's defence system can attack it.
The US Food and Drug Administration continues to seek jail sentences for vendors selling laetrile for cancer treatment, calling it a "highly toxic product that has not shown any effect on treating cancer."
A 2006 systematic review by the Cochrane Collaboration concluded: "The claim that [l]aetrile has beneficial effects for cancer patients is not supported by data from controlled clinical trials. This systematic review has clearly identified the need for randomised or controlled clinical trials assessing the effectiveness of [l]aetrile or amygdalin for cancer treatment." Given the lack of evidence, laetrile has not been approved by the U.S. Food and Drug Administration.
The U.S. National Institutes of Health evaluated the evidence separately and concluded that clinical trials of amgydalin showed little or no effect against cancer. For example, a 1982 trial of 178 patients found that tumor size had increased in all patients. The authors reported that "the hazards of amygdalin therapy were evidenced in several patients by symptoms of cyanide toxicity or by blood cyanide levels approaching the lethal range."
The study concluded "Patients exposed to this agent should be instructed about the danger of cyanide poisoning, and their blood cyanide levels should be carefully monitored. Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment".
Users browsing this forum: No registered users and 1 guest